Explore Over 11,000+ Conditions, Medications, and Symptoms.
Get a personalized feed by signing up for free.
All Conditions
Third or oculomotor nerve palsy
by Alike Medical Team ∙ Updated on June 13, 2023
The third cranial nerve, or the oculomotor nerve, is a nerve that controls most of the eye movements, the upper eyelid and is responsible for pupil constriction. In third nerve palsy, the patient will not be able to maintain a normal alignment of the eyes while staring straight, causing strabismus and double vision. Oculomotor nerve palsy may be congenital or acquired- caused by vascular disorders, tumors, inflammation, infection, trauma, multiple sclerosis, autoimmune disorders such as myasthenia gravis, post-operatively and as a result of cavernous sinus thrombosis.
3 people with Third or oculomotor nerve palsy are on Alike.
A complete third nerve palsy causes the eye to look outward and downward. Other symptoms include ptosis, pupil dilation, double vision and torticollis.
Diagnosis is based upon findings from medical history and physical examination. Further evaluation may include brain MRI, CT or angiography.
Treatment depends on the underlying cause and if the palsy is complete or partial. The treatment of choice is usually surgical. Other treatments are given as supportive care and include closing the eyes, and botox injections.
☝ We provide information on prescription and over-the-counter medicines, diagnosis, procedures and lab tests. This material is provided for educational purposes only and is not medical advice, diagnosis or treatment.
National Institutes of Health ∙ World Health Organization ∙ MedlinePluse ∙ Centers for Disease Control and Prevention
☝ All information has been reviewed by certified physicians from Alike
Alike is a transformative platform that goes beyond just bringing together patients; it meticulously connects individuals based on multiple critical factors, such as age, gender, comorbidities, medications, diet, and more, fostering a community of knowledge, support and empathy.
© 2020-2024 Alike, Inc